N/A Completed N=26

The PreOperative Management of Patients Awaiting Anterior Cruciate Ligament Reconstruction

Anterior Cruciate Ligament Injuries · Anterior Cruciate Ligament Rupture · Rehabilitation

Source: ClinicalTrials.gov NCT05529511 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2025

Primary outcomePrimary: Number of Participants Who Completed Semi-structured Interviews — 18; 0; 8; 12 Participants

Summary

Patient experiences of the NHS ACL treatment pathway are unknown. This study aims to explore patient experiences of anterior cruciate ligament ruptures at three different time points on the patient pathway: (1) 12 participants up to 2 weeks before surgery, (2) 12 participants 3 months after surgery, (3) 12 participants 12 months after surgery.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Who Completed Semi-structured Interviews	18; 0; 8; 12; 18	—
PRIMARY Number of Participants in the Nominal Group Technique Panel	0; 2; 0; 5; 0; 1	—

Eligibility Criteria

Inclusion Criteria

Phase 1:

≥ 18-years-old
Patient who is awaiting or has previously had an ACLR in the NHS

Phase 2

≥ 18-years-old
Participants will be in one of the following categories:
Healthcare professional in the NHS with a special interest/expertise in treating ACL injuries (must have treated a patient prior to or post ACLR within the last 2 years)
Therapy manager of an NHS musculoskeletal outpatient therapy department
Patient who is awaiting or has previously had an ACLR in the NHS

Exclusion Criteria

Phase 1:

Concomitant injuries requiring surgical intervention that will significantly alter the postoperative rehabilitation protocol e.g. meniscal repair requiring a non-weight bearing period
Previous knee surgery to the affected limb
Co-existing injuries requiring surgical intervention impacting on the individual's participation in pre-or post-operative rehabilitation
Pregnancy

Phase 2:

(1) Anyone with a recognised conflict of interest

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05529511). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.